These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Biliverdin inhibits Toll-like receptor-4 (TLR4) expression through nitric oxide-dependent nuclear translocation of biliverdin reductase. Wegiel B; Gallo D; Csizmadia E; Roger T; Kaczmarek E; Harris C; Zuckerbraun BS; Otterbein LE Proc Natl Acad Sci U S A; 2011 Nov; 108(46):18849-54. PubMed ID: 22042868 [TBL] [Abstract][Full Text] [Related]
3. Heme-oxygenase-1-induced protection against hypoxia/reoxygenation is dependent on biliverdin reductase and its interaction with PI3K/Akt pathway. Pachori AS; Smith A; McDonald P; Zhang L; Dzau VJ; Melo LG J Mol Cell Cardiol; 2007 Nov; 43(5):580-92. PubMed ID: 17920074 [TBL] [Abstract][Full Text] [Related]
4. Go green: the anti-inflammatory effects of biliverdin reductase. Wegiel B; Otterbein LE Front Pharmacol; 2012; 3():47. PubMed ID: 22438844 [TBL] [Abstract][Full Text] [Related]
5. Human heme oxygenase-1 efficiently catabolizes heme in the absence of biliverdin reductase. Reed JR; Huber WJ; Backes WL Drug Metab Dispos; 2010 Nov; 38(11):2060-6. PubMed ID: 20679134 [TBL] [Abstract][Full Text] [Related]
6. Interaction of human biliverdin reductase with Akt/protein kinase B and phosphatidylinositol-dependent kinase 1 regulates glycogen synthase kinase 3 activity: a novel mechanism of Akt activation. Miralem T; Lerner-Marmarosh N; Gibbs PE; Jenkins JL; Heimiller C; Maines MD FASEB J; 2016 Aug; 30(8):2926-44. PubMed ID: 27166089 [TBL] [Abstract][Full Text] [Related]
7. Loss of biliverdin reductase-A favors Tau hyper-phosphorylation in Alzheimer's disease. Sharma N; Tramutola A; Lanzillotta C; Arena A; Blarzino C; Cassano T; Butterfield DA; Di Domenico F; Perluigi M; Barone E Neurobiol Dis; 2019 May; 125():176-189. PubMed ID: 30738142 [TBL] [Abstract][Full Text] [Related]
8. Small interference RNA-mediated gene silencing of human biliverdin reductase, but not that of heme oxygenase-1, attenuates arsenite-mediated induction of the oxygenase and increases apoptosis in 293A kidney cells. Miralem T; Hu Z; Torno MD; Lelli KM; Maines MD J Biol Chem; 2005 Apr; 280(17):17084-92. PubMed ID: 15741166 [TBL] [Abstract][Full Text] [Related]
9. Biliverdin reductase mediates hypoxia-induced EMT via PI3-kinase and Akt. Zeng R; Yao Y; Han M; Zhao X; Liu XC; Wei J; Luo Y; Zhang J; Zhou J; Wang S; Ma D; Xu G J Am Soc Nephrol; 2008 Feb; 19(2):380-7. PubMed ID: 18184861 [TBL] [Abstract][Full Text] [Related]
10. Limited role for the bilirubin-biliverdin redox amplification cycle in the cellular antioxidant protection by biliverdin reductase. Maghzal GJ; Leck MC; Collinson E; Li C; Stocker R J Biol Chem; 2009 Oct; 284(43):29251-9. PubMed ID: 19690164 [TBL] [Abstract][Full Text] [Related]
11. Conversion of biliverdin to bilirubin by biliverdin reductase contributes to endothelial cell protection by heme oxygenase-1-evidence for direct and indirect antioxidant actions of bilirubin. Jansen T; Hortmann M; Oelze M; Opitz B; Steven S; Schell R; Knorr M; Karbach S; Schuhmacher S; Wenzel P; Münzel T; Daiber A J Mol Cell Cardiol; 2010 Aug; 49(2):186-95. PubMed ID: 20430037 [TBL] [Abstract][Full Text] [Related]
12. Biliverdin reductase as a target in drug research and development: Facts and hypotheses. Mancuso C Free Radic Biol Med; 2021 Aug; 172():521-529. PubMed ID: 34224815 [TBL] [Abstract][Full Text] [Related]
13. Deletion of Biliverdin Reductase A in Myeloid Cells Promotes Chemokine Expression and Chemotaxis in Part via a Complement C5a--C5aR1 Pathway. Bisht K; Canesin G; Cheytan T; Li M; Nemeth Z; Csizmadia E; Woodruff TM; Stec DE; Bulmer AC; Otterbein LE; Wegiel B J Immunol; 2019 May; 202(10):2982-2990. PubMed ID: 30952817 [TBL] [Abstract][Full Text] [Related]
15. The Janus face of the heme oxygenase/biliverdin reductase system in Alzheimer disease: it's time for reconciliation. Barone E; Di Domenico F; Mancuso C; Butterfield DA Neurobiol Dis; 2014 Feb; 62():144-59. PubMed ID: 24095978 [TBL] [Abstract][Full Text] [Related]
16. Pleiotropic functions of biliverdin reductase: cellular signaling and generation of cytoprotective and cytotoxic bilirubin. Kapitulnik J; Maines MD Trends Pharmacol Sci; 2009 Mar; 30(3):129-37. PubMed ID: 19217170 [TBL] [Abstract][Full Text] [Related]
17. Biliverdin reductase: PKC interaction at the cross-talk of MAPK and PI3K signaling pathways. Maines MD Antioxid Redox Signal; 2007 Dec; 9(12):2187-95. PubMed ID: 17919068 [TBL] [Abstract][Full Text] [Related]
18. Biliverdin reductase: new features of an old enzyme and its potential therapeutic significance. Florczyk UM; Jozkowicz A; Dulak J Pharmacol Rep; 2008; 60(1):38-48. PubMed ID: 18276984 [TBL] [Abstract][Full Text] [Related]
19. Biliverdin Reductase A (BVRA) Mediates Macrophage Expression of Interleukin-10 in Injured Kidney. Hu Z; Pei G; Wang P; Yang J; Zhu F; Guo Y; Wang M; Yao Y; Zeng R; Liao W; Xu G Int J Mol Sci; 2015 Sep; 16(9):22621-35. PubMed ID: 26393580 [TBL] [Abstract][Full Text] [Related]
20. Biliverdin reductase/bilirubin mediates the anti-apoptotic effect of hypoxia in pulmonary arterial smooth muscle cells through ERK1/2 pathway. Song S; Wang S; Ma J; Yao L; Xing H; Zhang L; Liao L; Zhu D Exp Cell Res; 2013 Aug; 319(13):1973-1987. PubMed ID: 23722043 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]